Abstract:The striatum is believed to be a crucial brain region associated with drug reward. Adaptive alteration of neurochemistry in this area might be one potential mechanism underlying drug dependence. It has been proposed that the dysfunction of Na+, K+- ATPase function is involved in morphine tolerance and dependence. The present study, therefore, was undertaken to study the adaptation of the striatal Na+, K+- ATPase activity in response to morphine treatment. The results demonstrated that in vivo short- term morphine treatment stimulated Na+, K+- ATPase activity in a dose- dependent manner. This action could be significantly inhibited by D-2- like dopamine receptor antagonist S(-)- 3- chloro-5-ethyl-N-[(1- ethyl- 2- pyrrolidinyl) methyl]- 6hydroxy- 2- methoxybenzamine ( eticlopride). Contrary to shortterm morphine treatment, long- term morphine treatment significantly suppressed Na+, K+- ATPase activity. This effect could be significantly inhibited by D 1- like dopamine receptor antagonist R(+)- 7- chloro- 8- hydroxy- 3- methyl- 1- phenyl- 2,3,4,5tetrahydro- 1H-3- benzazepine hydrochloride (SCH 23390). However, both short- term and long- term morphine treatment-induced changes in Na+, K+- ATPase activity could be reversed by opioid receptor antagonist naltrexone. It was further found that cAMP- dependent protein kinase ( PKA) was crucially involved in regulating Na+, K+- ATPase activity by morphine. Different regulation of the phosphorylation levels of the alpha 3 subunit of Na+, K(+)ATPase by PKA was related to the distinct modulations of Na+, K+- ATPase by short- term and long- term morphine treatment. Short- term morphine treatment inhibited PKA activity and then decreased the phosphorylation of Na+, K+- ATPase, leading to increase in enzyme activity. These effects were sensitive to eticlopride or naltrexone. Conversely, long- term morphine treatment stimulated PKA activity and then increased the phosphorylation of Na+, K+- ATPase, leading to the reduction of enzyme activity. These effects were sensitive to SCH 23390 or naltrexone. These findings demonstrate that dopamine receptors are involved in regulation of Na+, K+- ATPase activity after activation of opioid receptors by morphine.

The α 1 adrenoceptor antagonist prazosin potentiates morphine induced conditioned place preference in rats

The Α1 Adrenoceptor Antagonist Prazosin Potentiates Morphine Induced Conditioned Place Preference in Rats.

Blocking Alpha(4)Beta(2) And Alpha(7) Nicotinic Acetylcholine Receptors Inhibits The Reinstatement Of Morphine-Induced Cpp By Drug Priming In Mice

The Α1 Adrenoceptors in Ventrolateral Orbital Cortex Contribute to the Expression of Morphine-Induced Behavioral Sensitization in Rats.

Upregulation of HCN2 in ventral tegmental area is involved in morphine‐induced conditioned place preference in rats

Inhibition of Phosphodiesterase10a Attenuates Morphine-Induced Conditioned Place Preference.

Effects of the novel, selective and low-efficacy mu opioid receptor ligand NAQ on intracranial self-stimulation in rats

The differential effects of OX1R and OX2R selective antagonists on morphine conditioned place preference in naïve versus morphine-dependent mice

Inhibition of PSD95‐nNOS protein–protein interactions decreases morphine reward and relapse vulnerability in rats

Morphine Coordinates SST and PV Interneurons in the Prelimbic Cortex to Disinhibit Pyramidal Neurons and Enhance Reward

Brain opioid-receptors are involved in mediating peripheral electric stimulation-induced inhibition of morphine conditioned place preference in rats

Dorsal Raphe Nucleus Serotoninergic Neurons Mediate Morphine Rewarding Effect and Conditioned Place Preference

Blockade of Cannabinoid CB1 Receptor Attenuates the Acquisition of Morphine-Induced Conditioned Place Preference along with a Downregulation of ERK, CREB Phosphorylation, and BDNF Expression in the Nucleus Accumbens and Hippocampus.

Reactivation of Morphine Conditioned Place Preference by Drug Priming: Role of Environmental Cues and Sensitization

The role of NR2B containing NMDA receptor in place preference conditioned with morphine and natural reinforcers in rats.

Dose- and Time-Dependent, Context-Induced Elevation of Dopamine and Its Metabolites in the Nucleus Accumbens of Morphine-Induced CPP Rats

Molecular Chaperone Heat Shock Protein 70 Inhibitors Suppress Conditioned Place Preference Induced by Morphine Exposure in Male Rats.

Epigenetic Upregulation of CXCL12 Expression Contributes to the Acquisition and Maintenance of Morphine-Induced Conditioned Place Preference.

Neuropeptide S inhibits the acquisition and the expression of conditioned place preference to morphine in mice.

Morphine treatment enhances glutamatergic input onto neurons of the nucleus accumbens via both disinhibitory and stimulating effect.

Involvement of dopamine system in regulation of Na+,K +-ATPase in the striatum upon activation of opioid receptors by morphine